| NCT04454983 |
Lipiflow vs iLux Patient Acceptance and Comfort Study |
https://ClinicalTrials.gov/show/NCT04454983 |
Completed |
Epstein, Arthur B., OD, FAAO |
2020-02-29 |
| NCT04457999 |
Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT04457999 |
Recruiting |
Samsung Medical Center |
2020-07-02 |
| NCT04457648 |
Manuka Honey Eye Drops VS Conventional Treatment of Meibomian Gland Dysfunction Related Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04457648 |
Completed |
Chinese University of Hong Kong |
2020-06-01 |
| NCT04393441 |
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04393441 |
Recruiting |
Allergan |
2020-11-27 |
| NCT03937882 |
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 |
https://ClinicalTrials.gov/show/NCT03937882 |
Recruiting |
ReGenTree, LLC |
2020-08-31 |
| NCT03396913 |
Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03396913 |
Completed |
Lumenis Ltd. |
2019-08-15 |
| NCT03368404 |
A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye |
https://ClinicalTrials.gov/show/NCT03368404 |
Active, not recruiting |
Laboratoire Chauvin |
2020-03-31 |
| NCT03520348 |
Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects. |
https://ClinicalTrials.gov/show/NCT03520348 |
Completed |
Laboratorios Sophia S.A de C.V. |
2018-05-22 |
| NCT03821415 |
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03821415 |
Completed |
Redwood Pharma AB |
2019-11-18 |
| NCT03334539 |
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes |
https://ClinicalTrials.gov/show/NCT03334539 |
Completed |
HanAll BioPharma Co., Ltd. |
2018-05-31 |
| NCT03333057 |
Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03333057 |
Completed |
Novaliq GmbH |
2018-05-18 |
| NCT03332342 |
Closed Eye Neutrophils in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03332342 |
Completed |
University of Alabama at Birmingham |
2018-12-12 |
| NCT03319420 |
Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT03319420 |
Recruiting |
Ocuwize LTD |
2020-09-30 |
| NCT03318874 |
Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction |
https://ClinicalTrials.gov/show/NCT03318874 |
Active, not recruiting |
Oslo University Hospital |
2020-04-15 |
| NCT03302273 |
Corneal Epithelial Stem Cells and Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03302273 |
Enrolling by invitation |
Panhandle Eye Group, LLP |
2021-02-01 |
| NCT03292809 |
CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03292809 |
Completed |
Novaliq GmbH |
2018-05-22 |
| NCT03287635 |
Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03287635 |
Recruiting |
Toyos Clinic |
2020-05-31 |
| NCT03265652 |
IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGD |
https://ClinicalTrials.gov/show/NCT03265652 |
Completed |
Lumenis Ltd. |
2019-04-18 |
| NCT03265327 |
Effect of an Oral Supplement Containing Omega-3 and Omega-6 on Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT03265327 |
Completed |
Nature’s Way Canada |
2018-06-27 |
| NCT03228784 |
The Effect of Ablation Depth on Dry Eye After LASIK Treatment of Myopia |
https://ClinicalTrials.gov/show/NCT03228784 |
Completed |
Minia University |
2014-05-01 |
| NCT03226444 |
Lacripepâ„¢ in Subjects With Dry Eye Associated With Primary Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT03226444 |
Completed |
TearSolutions, Inc. |
2019-12-27 |
| NCT03216096 |
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03216096 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2018-02-01 |
| NCT03211351 |
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03211351 |
Completed |
Huaxia Eye Hospital Group |
2017-12-01 |
| NCT03208673 |
Optive Brand For Day And Night Dry Eye Management |
https://ClinicalTrials.gov/show/NCT03208673 |
Completed |
Allergan |
2017-09-06 |
| NCT03204903 |
Laser Acupuncture for Dry Eye |
https://ClinicalTrials.gov/show/NCT03204903 |
Recruiting |
Chang Gung Memorial Hospital |
2019-07-31 |
| NCT03194698 |
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea |
https://ClinicalTrials.gov/show/NCT03194698 |
Completed |
Mayo Clinic |
2018-12-06 |
| NCT03183089 |
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT03183089 |
Completed |
The Mentholatum Company |
2016-01-04 |
| NCT03162783 |
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03162783 |
Completed |
Aldeyra Therapeutics, Inc. |
2017-07-06 |
| NCT03161080 |
Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03161080 |
Completed |
Medical University of Vienna |
2017-05-12 |
| NCT03141931 |
The Effects of Dietary Supplementation With Omega-3 Fatty Acids on Symptoms of Dry Eye |
https://ClinicalTrials.gov/show/NCT03141931 |
Completed |
The University of New South Wales |
2018-10-19 |
| NCT03116776 |
Walnut Shell Glasses Moxibustion for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03116776 |
Recruiting |
Guang’anmen Hospital of China Academy of Chinese Medical Sciences |
2018-07-30 |
| NCT03108664 |
HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03108664 |
Completed |
Sylentis, S.A. |
2018-10-16 |
| NCT03097614 |
Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment |
https://ClinicalTrials.gov/show/NCT03097614 |
Completed |
Oculeve, Inc. |
2017-06-26 |
| NCT03088605 |
Safety and Efficacy of TOP1630 for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03088605 |
Completed |
Topivert Pharma Ltd |
2017-06-15 |
| NCT03085290 |
Allogeneic Versus Autologous Serum Eye Drops |
https://ClinicalTrials.gov/show/NCT03085290 |
Completed |
Sanquin Research & Blood Bank Divisions |
2018-10-08 |
| NCT03074344 |
Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT03074344 |
Completed |
Azienda Ospedaliera Universitaria Policlinico “G. Martino” |
2016-07-31 |
| NCT03066219 |
Safety and Efficacy of BRM421 for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03066219 |
Completed |
BRIM Biotechnology Inc. |
2017-05-20 |
| NCT03052140 |
Lamelleye vs Comparator for the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03052140 |
Completed |
Glasgow Caledonian University |
2017-08-09 |
| NCT03019627 |
An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT03019627 |
Completed |
Dompé Farmaceutici S.p.A |
2017-08-31 |
| NCT03012698 |
Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT03012698 |
Completed |
Epitech Mag Ltd. |
2019-06-17 |
| NCT02980913 |
Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02980913 |
Completed |
Medical University of Vienna |
2016-05-17 |
| NCT02980224 |
Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02980224 |
Completed |
OmegaD LLC |
2017-02-28 |
| NCT02975102 |
A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye |
https://ClinicalTrials.gov/show/NCT02975102 |
Completed |
Laboratoire Chauvin |
2019-09-17 |
| NCT02974907 |
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2 |
https://ClinicalTrials.gov/show/NCT02974907 |
Completed |
ReGenTree, LLC |
2017-09-30 |
| NCT02951910 |
A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT02951910 |
Completed |
Semmelweis University |
2016-08-31 |
| NCT02917512 |
Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02917512 |
Completed |
Huons Co., Ltd. |
2016-12-31 |
| NCT02910713 |
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation |
https://ClinicalTrials.gov/show/NCT02910713 |
Completed |
Allergan |
2016-10-31 |
| NCT02908282 |
Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT02908282 |
Completed |
TRB Chemedica AG |
2018-07-31 |
| NCT02871440 |
A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye |
https://ClinicalTrials.gov/show/NCT02871440 |
Completed |
The University of New South Wales |
2017-09-18 |
| NCT02848222 |
Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers |
https://ClinicalTrials.gov/show/NCT02848222 |
Completed |
University of Alabama at Birmingham |
2017-12-31 |
| NCT02845674 |
An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT02845674 |
Completed |
Sun Pharma Global FZE |
2017-08-15 |
| NCT02819284 |
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02819284 |
Completed |
Kala Pharmaceuticals, Inc. |
2017-09-30 |
| NCT02813265 |
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02813265 |
Completed |
Kala Pharmaceuticals, Inc. |
2017-10-31 |
| NCT02802150 |
The Effect of Oral Zanthoxylum Schinifolium Seed Oil in Individuals With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02802150 |
Completed |
Chonbuk National University Hospital |
2015-07-31 |
| NCT02798289 |
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator |
https://ClinicalTrials.gov/show/NCT02798289 |
Completed |
Oculeve, Inc. |
2016-08-31 |
| NCT02776670 |
Clinical Outcomes Following Treatment With SYSTANE® BALANCE |
https://ClinicalTrials.gov/show/NCT02776670 |
Completed |
Alcon Research |
2017-11-22 |
| NCT02764814 |
In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye |
https://ClinicalTrials.gov/show/NCT02764814 |
Completed |
Tissue Tech Inc. |
2016-09-30 |
| NCT02752763 |
Comparison of Autologous Serum Versus Preservative Free Artificial Tear |
https://ClinicalTrials.gov/show/NCT02752763 |
Completed |
NiÄŸde State Hospital |
2016-03-31 |
| NCT02701764 |
Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis? |
https://ClinicalTrials.gov/show/NCT02701764 |
Completed |
University of Miami |
2018-12-01 |
| NCT02688556 |
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT02688556 |
Completed |
Sun Pharma Global FZE |
2016-11-30 |
| NCT02683382 |
Effects of a Moisturizing Product on Dry Eye and Skin |
https://ClinicalTrials.gov/show/NCT02683382 |
Completed |
Aromtech Ltd. |
2016-06-30 |
| NCT02680158 |
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02680158 |
Completed |
Oculeve, Inc. |
2016-03-31 |
| NCT02665234 |
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02665234 |
Completed |
Mimetogen Pharmaceuticals USA, Inc. |
2017-02-28 |
| NCT02634853 |
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT02634853 |
Completed |
Mimetogen Pharmaceuticals USA, Inc. |
2017-02-28 |
| NCT02621593 |
Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD |
https://ClinicalTrials.gov/show/NCT02621593 |
Completed |
Lumenis Ltd. |
2017-01-31 |
| NCT02617667 |
CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT02617667 |
Completed |
Novaliq GmbH |
2016-07-31 |
| NCT02608489 |
Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT02608489 |
Completed |
Soonchunhyang University Hospital |
2015-01-31 |
| NCT02597803 |
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1 |
https://ClinicalTrials.gov/show/NCT02597803 |
Completed |
ReGenTree, LLC |
2016-06-30 |
| NCT02585648 |
Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02585648 |
Completed |
Medical University of Vienna |
2016-05-31 |
| NCT02585453 |
Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02585453 |
Completed |
Medical University of Vienna |
2015-09-30 |
| NCT03404115 |
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03404115 |
Completed |
Aldeyra Therapeutics, Inc. |
2018-07-11 |
| NCT02553772 |
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease. |
https://ClinicalTrials.gov/show/NCT02553772 |
Completed |
Allergan |
2016-09-09 |
| NCT02526290 |
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator |
https://ClinicalTrials.gov/show/NCT02526290 |
Completed |
Oculeve, Inc. |
2016-04-30 |
| NCT02510235 |
Tolerability, Safety and Efficacy of Lubricin Eye Drops vs Sodium Hyaluronate Eye Drops in Subjects With Mod. Dry Eye |
https://ClinicalTrials.gov/show/NCT02510235 |
Completed |
Dompé Farmaceutici S.p.A |
2015-05-31 |
| NCT02507934 |
Tolerability, Safety and Efficacy of Lubricin (150 µg/ml) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops in Patients With Moderate Dry Eye (DE) |
https://ClinicalTrials.gov/show/NCT02507934 |
Completed |
Dompé Farmaceutici S.p.A |
2015-08-31 |
| NCT02503189 |
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT02503189 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
2017-01-31 |
| NCT02503163 |
A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT02503163 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
2017-10-19 |
| NCT02470429 |
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION |
https://ClinicalTrials.gov/show/NCT02470429 |
Completed |
Alcon Research |
2016-05-26 |
| NCT02468700 |
OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT02468700 |
Completed |
Ocular Therapeutix, Inc. |
2015-08-31 |
| NCT02455050 |
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief |
https://ClinicalTrials.gov/show/NCT02455050 |
Completed |
Allergan |
2015-08-31 |
| NCT02446015 |
Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye |
https://ClinicalTrials.gov/show/NCT02446015 |
Completed |
Alcon Research |
2016-06-21 |
| NCT02435914 |
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02435914 |
Completed |
Allergan |
2016-01-31 |
| NCT02420834 |
Dry Eye Treatment With Artificial Tears |
https://ClinicalTrials.gov/show/NCT02420834 |
Completed |
Aston University |
2019-01-31 |
| NCT02420730 |
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye |
https://ClinicalTrials.gov/show/NCT02420730 |
Completed |
Allergan |
2016-03-31 |
| NCT02417116 |
Tear Osmolarity Clinical Utility in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02417116 |
Completed |
Aston University |
2019-01-31 |
| NCT02403219 |
Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry Eye |
https://ClinicalTrials.gov/show/NCT02403219 |
Completed |
Instituto de OftalmologÃa Fundación Conde de Valenciana |
2014-02-28 |
| NCT02385292 |
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation |
https://ClinicalTrials.gov/show/NCT02385292 |
Completed |
Oculeve, Inc. |
2016-03-31 |
| NCT02380248 |
Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects |
https://ClinicalTrials.gov/show/NCT02380248 |
Completed |
Alcon Research |
2016-06-01 |
| NCT02369861 |
Study of ST266 Eye Drops in Treating Dry Eye |
https://ClinicalTrials.gov/show/NCT02369861 |
Completed |
Noveome Biotherapeutics, formerly Stemnion |
2015-10-31 |
| NCT02365519 |
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02365519 |
Completed |
Alcon Research |
2015-10-16 |
| NCT02326090 |
Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye |
https://ClinicalTrials.gov/show/NCT02326090 |
Completed |
Herantis Pharma Plc. |
2015-04-30 |
| NCT02313454 |
Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT02313454 |
Completed |
Allergan |
2015-04-08 |
| NCT02284516 |
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) |
https://ClinicalTrials.gov/show/NCT02284516 |
Completed |
Shire |
2015-10-05 |
| NCT02280473 |
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02280473 |
Completed |
Allergan |
2015-03-16 |
| NCT02260960 |
The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02260960 |
Completed |
Physician Recommended Nutriceuticals |
2015-03-31 |
| NCT02254265 |
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT02254265 |
Completed |
Sun Pharma Global FZE |
2015-05-31 |
| NCT02242032 |
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02242032 |
Completed |
Parion Sciences |
2015-03-31 |
| NCT02235259 |
Efficacy and Safety of XG-104 for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT02235259 |
Completed |
Xigen SA |
2015-02-28 |
| NCT02229955 |
Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02229955 |
Completed |
Hanlim Pharm. Co., Ltd. |
2014-04-30 |
| NCT02219204 |
Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye |
https://ClinicalTrials.gov/show/NCT02219204 |
Completed |
Singapore National Eye Centre |
2015-12-31 |
| NCT02210793 |
Dry Eye Evaluation After Transepithelial PRK |
https://ClinicalTrials.gov/show/NCT02210793 |
Completed |
AL-Nour Eye Hospital |
2013-03-31 |
| NCT02205840 |
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye. |
https://ClinicalTrials.gov/show/NCT02205840 |
Completed |
Seikagaku Corporation |
2014-11-30 |
| NCT02188160 |
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02188160 |
Completed |
Kala Pharmaceuticals, Inc. |
2015-01-31 |
| NCT02147509 |
Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren’s Syndrome |
https://ClinicalTrials.gov/show/NCT02147509 |
Completed |
Wenzhou Medical University |
2014-04-30 |
| NCT02139033 |
A Phase 4 Study Investigating the Efficacy of Retaineâ„¢ in Managing Signs and Symptoms Associated With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02139033 |
Completed |
Ocusoft, Inc. |
2014-05-31 |
| NCT02128763 |
Dry Eye Assessment and Management Study |
https://ClinicalTrials.gov/show/NCT02128763 |
Completed |
University of Pennsylvania |
2017-09-05 |
| NCT02121301 |
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02121301 |
Completed |
Mitotech, SA |
2014-05-31 |
| NCT02120079 |
The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED |
https://ClinicalTrials.gov/show/NCT02120079 |
Completed |
Tufts Medical Center |
2017-04-30 |
| NCT02117687 |
A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye |
https://ClinicalTrials.gov/show/NCT02117687 |
Completed |
Allergan |
2015-01-27 |
| NCT02116244 |
Civamide Nasal Solution for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT02116244 |
Completed |
Winston Laboratories |
2015-09-30 |
| NCT02102464 |
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers |
https://ClinicalTrials.gov/show/NCT02102464 |
Completed |
TearScience, Inc. |
2015-08-31 |
| NCT02101281 |
Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT02101281 |
Completed |
Dompé Farmaceutici S.p.A |
2015-01-31 |
| NCT02092207 |
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02092207 |
Completed |
Yungjin Pharm. Co., Ltd. |
2014-06-30 |
| NCT02078661 |
Safety and Efficacy of PG101 for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02078661 |
Completed |
Rhodes Pharmaceuticals, L.P. |
2014-01-31 |
| NCT01311609 |
A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients |
https://ClinicalTrials.gov/show/NCT01311609 |
Completed |
Alcon Research |
2011-07-31 |
| NCT01294956 |
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D) |
https://ClinicalTrials.gov/show/NCT01294956 |
Completed |
Alcon Research |
2011-04-30 |
| NCT01294384 |
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01294384 |
Completed |
Allergan |
2012-09-25 |
| NCT01278784 |
Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers |
https://ClinicalTrials.gov/show/NCT01278784 |
Completed |
Medical University of Vienna |
2011-06-30 |
| NCT01276223 |
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01276223 |
Completed |
Alcon Research |
2012-01-31 |
| NCT02023268 |
Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02023268 |
Completed |
Laboratoires Thea |
2014-12-31 |
| NCT02051023 |
Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca) |
https://ClinicalTrials.gov/show/NCT02051023 |
Completed |
Instituto Universitario de OftalmobiologÃa Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
2014-12-31 |
| NCT02040623 |
Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2) |
https://ClinicalTrials.gov/show/NCT02040623 |
Completed |
Rigel Pharmaceuticals |
2016-07-31 |
| NCT02028754 |
A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT02028754 |
Completed |
Allergan |
2013-05-31 |
| NCT03785340 |
Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03785340 |
Completed |
Ocugen |
2019-02-28 |
| NCT02014922 |
A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN) |
https://ClinicalTrials.gov/show/NCT02014922 |
Completed |
University of Waterloo |
2014-11-30 |
| NCT02004067 |
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT02004067 |
Completed |
Federal University of São Paulo |
2016-08-31 |
| NCT01998802 |
Phase 3 Study of EBI-005 in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01998802 |
Completed |
Eleven Biotherapeutics |
2015-03-31 |
| NCT01991132 |
Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian Glands |
https://ClinicalTrials.gov/show/NCT01991132 |
Completed |
Singapore National Eye Centre |
2014-12-31 |
| NCT01967147 |
Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects |
https://ClinicalTrials.gov/show/NCT01967147 |
Completed |
Alcon Research |
2015-01-31 |
| NCT01960010 |
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT01960010 |
Completed |
Mimetogen Pharmaceuticals USA, Inc. |
2014-08-31 |
| NCT01959854 |
Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01959854 |
Completed |
SIFI SpA |
2014-10-31 |
| NCT01933178 |
Reproducibility of Anterior Segment Optical Coherence Tomography (AS-OCT) for Imaging Conjunctivochalasis |
https://ClinicalTrials.gov/show/NCT01933178 |
Completed |
Singapore National Eye Centre |
2014-02-28 |
| NCT01918410 |
Effect of Contact Lens With Alginic Acid in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01918410 |
Completed |
Singapore National Eye Centre |
2014-12-31 |
| NCT01900249 |
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT01900249 |
Completed |
Rigel Pharmaceuticals |
2014-07-31 |
| NCT01880463 |
Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL) |
https://ClinicalTrials.gov/show/NCT01880463 |
Active, not recruiting |
Brigham and Women’s Hospital |
2020-12-31 |
| NCT01864330 |
Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01864330 |
Completed |
Medical University of Vienna |
2013-08-31 |
| NCT01863368 |
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining |
https://ClinicalTrials.gov/show/NCT01863368 |
Completed |
Alcon Research |
2014-06-30 |
| NCT01850979 |
Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops |
https://ClinicalTrials.gov/show/NCT01850979 |
Completed |
University of Sao Paulo General Hospital |
2011-11-30 |
| NCT01843894 |
A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT01843894 |
Completed |
R-Tech Ueno, Ltd. |
2014-07-31 |
| NCT01833117 |
Efficacy and Safety Study of FID 119515A |
https://ClinicalTrials.gov/show/NCT01833117 |
Completed |
Alcon Research |
2013-06-30 |
| NCT01817582 |
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease) |
https://ClinicalTrials.gov/show/NCT01817582 |
Completed |
Bausch & Lomb Incorporated |
2014-01-10 |
| NCT01804361 |
Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes |
https://ClinicalTrials.gov/show/NCT01804361 |
Completed |
DH Bio Co., Ltd. |
2014-02-28 |
| NCT01797822 |
Effects of Dry Eye Treatments on the Ocular Surface |
https://ClinicalTrials.gov/show/NCT01797822 |
Completed |
Baylor College of Medicine |
2015-12-31 |
| NCT01776658 |
Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain |
https://ClinicalTrials.gov/show/NCT01776658 |
Completed |
Sylentis, S.A. |
2015-04-30 |
| NCT01775540 |
Systane Ultra Versus Maxidex Versus Saline |
https://ClinicalTrials.gov/show/NCT01775540 |
Completed |
Icahn School of Medicine at Mount Sinai |
2012-10-31 |
| NCT01768312 |
Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension Group |
https://ClinicalTrials.gov/show/NCT01768312 |
Completed |
Hanlim Pharm. Co., Ltd. |
2013-07-31 |
| NCT01753752 |
Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation |
https://ClinicalTrials.gov/show/NCT01753752 |
Completed |
Medical University of Vienna |
2013-03-31 |
| NCT01753687 |
Correlation of Different Signs for Assessment of Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01753687 |
Completed |
Medical University of Vienna |
2013-07-31 |
| NCT01748578 |
Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT01748578 |
Completed |
Eleven Biotherapeutics |
2012-11-30 |
| NCT01745887 |
A Multi-Center Study Subjects With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01745887 |
Completed |
Eleven Biotherapeutics |
2012-11-30 |
| NCT01744457 |
Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01744457 |
Completed |
Medical University of Vienna |
2012-02-29 |
| NCT01743729 |
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye |
https://ClinicalTrials.gov/show/NCT01743729 |
Completed |
Shire |
2013-10-01 |
| NCT01742884 |
Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz |
https://ClinicalTrials.gov/show/NCT01742884 |
Completed |
Instituto Universitario de OftalmobiologÃa Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
2014-06-30 |
| NCT01733992 |
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01733992 |
Completed |
Rigel Pharmaceuticals |
2013-02-28 |
| NCT01733745 |
SYSTANE® Family - Meibomian Deficiency |
https://ClinicalTrials.gov/show/NCT01733745 |
Completed |
Alcon Research |
2013-06-30 |
| NCT01733732 |
SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers |
https://ClinicalTrials.gov/show/NCT01733732 |
Completed |
Alcon Research |
2013-10-31 |
| NCT01692145 |
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes |
https://ClinicalTrials.gov/show/NCT01692145 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
NA |
| NCT01688726 |
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency |
https://ClinicalTrials.gov/show/NCT01688726 |
Completed |
Alcon Research |
2013-11-30 |
| NCT01684436 |
Safety and Efficacy of Punctal Plug Insertion in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01684436 |
Completed |
Allergan |
2013-07-31 |
| NCT01682460 |
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients |
https://ClinicalTrials.gov/show/NCT01682460 |
Completed |
University of Waterloo |
2013-04-30 |
| NCT01675570 |
A Study of RX-10045 in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01675570 |
Completed |
C.T. Development America, Inc. |
2012-11-30 |
| NCT01670357 |
Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01670357 |
Completed |
Dong-A ST Co., Ltd. |
2013-03-31 |
| NCT01664949 |
A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVEâ„¢ in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01664949 |
Completed |
Allergan |
2014-05-31 |
| NCT01660256 |
Confirmatory Study of OPC-12759 Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT01660256 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2013-03-31 |
| NCT01657253 |
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye |
https://ClinicalTrials.gov/show/NCT01657253 |
Completed |
Laboratorios Sophia S.A de C.V. |
2015-02-28 |
| NCT01650584 |
Evaluation of Ocular Comfort With ISTA Tears vs Systane |
https://ClinicalTrials.gov/show/NCT01650584 |
Completed |
Bausch & Lomb Incorporated |
2012-12-31 |
| NCT01636206 |
Safety Study of Lifitegrast to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT01636206 |
Completed |
Shire |
2014-03-03 |
| NCT01632137 |
Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01632137 |
Completed |
Kubota Vision Inc. |
2013-06-30 |
| NCT01614847 |
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears |
https://ClinicalTrials.gov/show/NCT01614847 |
Completed |
Northeastern State University |
2012-08-31 |
| NCT01614600 |
Clinical Evaluation of a Daily Disposable Contact Lens in Symptomatic Weekly/Monthly Lens Wearers |
https://ClinicalTrials.gov/show/NCT01614600 |
Completed |
Alcon Research |
2012-09-30 |
| NCT01601028 |
Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT01601028 |
Completed |
Seoul National University Hospital |
2013-08-31 |
| NCT01579539 |
The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy |
https://ClinicalTrials.gov/show/NCT01579539 |
Completed |
Medical University of Vienna |
2017-05-18 |
| NCT01568593 |
Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01568593 |
Completed |
Laboratoires Thea |
2013-03-31 |
| NCT01562795 |
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01562795 |
Completed |
Wenzhou Medical University |
2012-06-30 |
| NCT01558999 |
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01558999 |
Completed |
Seikagaku Corporation |
2012-07-31 |
| NCT01543061 |
Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints |
https://ClinicalTrials.gov/show/NCT01543061 |
Completed |
Optometric Technology Group Ltd |
2012-09-30 |
| NCT01541891 |
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01541891 |
Completed |
Laboratorios Sophia S.A de C.V. |
2012-03-31 |
| NCT01521507 |
Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry Eye |
https://ClinicalTrials.gov/show/NCT01521507 |
Completed |
TearScience, Inc. |
2013-11-30 |
| NCT01483989 |
In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01483989 |
Completed |
Alcon Research |
2011-06-30 |
| NCT01468168 |
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01468168 |
Completed |
Santen Inc. |
2012-11-30 |
| NCT01459588 |
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01459588 |
Completed |
Allergan |
2012-02-15 |
| NCT01434277 |
Safety Evaluation of a New Preservative in a Lubricating Eye Drop |
https://ClinicalTrials.gov/show/NCT01434277 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2011-04-30 |
| NCT01427816 |
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01427816 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
NA |
| NCT01421498 |
Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1) |
https://ClinicalTrials.gov/show/NCT01421498 |
Completed |
Shire |
2012-04-28 |
| NCT01393132 |
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT01393132 |
Completed |
Michigan Cornea Consultants, PC |
2012-12-31 |
| NCT01388426 |
Moisture Chamber Glasses for Dry Eye in Asian Population |
https://ClinicalTrials.gov/show/NCT01388426 |
Completed |
Singapore National Eye Centre |
2012-08-31 |
| NCT01382225 |
Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01382225 |
Completed |
Alcon Research |
2012-05-31 |
| NCT01375582 |
Objective Evaluation of Ocular Surface Lubricants in Two Environments |
https://ClinicalTrials.gov/show/NCT01375582 |
Completed |
University of Rochester |
2012-06-30 |
| NCT01363414 |
Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes |
https://ClinicalTrials.gov/show/NCT01363414 |
Completed |
Ramathibodi Hospital |
2010-06-30 |
| NCT01339936 |
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers |
https://ClinicalTrials.gov/show/NCT01339936 |
Completed |
Optometric Technology Group Ltd |
2011-08-31 |
| NCT01319773 |
Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01319773 |
Completed |
Allergan |
2011-01-31 |
| NCT04425551 |
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction |
https://ClinicalTrials.gov/show/NCT04425551 |
Active, not recruiting |
Naval Hospital, Athens |
2020-09-30 |
| NCT04384991 |
HU007 Eye Drops in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT04384991 |
Completed |
Huons Co., Ltd. |
2019-12-05 |
| NCT04362670 |
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease. |
https://ClinicalTrials.gov/show/NCT04362670 |
Active, not recruiting |
Ocular Therapeutix, Inc. |
2020-11-30 |
| NCT04343287 |
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT04343287 |
Recruiting |
BRIM Biotechnology Inc. |
2020-04-30 |
| NCT04342988 |
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery |
https://ClinicalTrials.gov/show/NCT04342988 |
Active, not recruiting |
Research Insight LLC |
2020-11-30 |
| NCT04320563 |
Rexon-Eye in Dry Eye |
https://ClinicalTrials.gov/show/NCT04320563 |
Recruiting |
Singapore National Eye Centre |
2021-11-30 |
| NCT04310969 |
Clinical Effect of MiboFlo in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT04310969 |
Enrolling by invitation |
Beijing Tongren Hospital |
2020-05-30 |
| NCT04268069 |
Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye |
https://ClinicalTrials.gov/show/NCT04268069 |
Recruiting |
ORA, Inc. |
2020-07-31 |
| NCT04260893 |
Prospective Study To Assess The Safety And Effectiveness Of Tixel Treatment On Dry Eye Symptoms In Asian Patients |
https://ClinicalTrials.gov/show/NCT04260893 |
Recruiting |
Novoxel Ltd. |
2021-04-30 |
| NCT03452397 |
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) |
https://ClinicalTrials.gov/show/NCT03452397 |
Completed |
Oyster Point Pharma, Inc. |
2018-05-16 |
| NCT04237012 |
ACCURATE Study for Subjects With Dry Eyes |
https://ClinicalTrials.gov/show/NCT04237012 |
Recruiting |
The Eye Centers of Racine and Kenosha |
2020-12-30 |
| NCT04213248 |
Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD |
https://ClinicalTrials.gov/show/NCT04213248 |
Recruiting |
Zhongshan Ophthalmic Center, Sun Yat-sen University |
2020-05-31 |
| NCT04206020 |
Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome |
https://ClinicalTrials.gov/show/NCT04206020 |
Recruiting |
Mitotech, SA |
2020-09-15 |
| NCT04201574 |
Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04201574 |
Recruiting |
Allysta Pharmaceutical |
2020-08-31 |
| NCT04184999 |
Effect of Intraoperative Dexamethasone on Post-op Dry Eye |
https://ClinicalTrials.gov/show/NCT04184999 |
Active, not recruiting |
SR Cornea Consultants |
2019-12-31 |
| NCT04181593 |
Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04181593 |
Recruiting |
OmegaD LLC |
2020-07-31 |
| NCT04172961 |
Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days |
https://ClinicalTrials.gov/show/NCT04172961 |
Recruiting |
Toyos Clinic |
2020-05-01 |
| NCT04165785 |
Efficiency and Changes of Cytokines Expression in Tear After Intense Pulsed Light Treating Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04165785 |
Completed |
First Affiliated Hospital of Harbin Medical University |
2019-06-28 |
| NCT04159935 |
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04159935 |
Recruiting |
University of Waterloo |
2020-06-30 |
| NCT04147650 |
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT04147650 |
Recruiting |
Aurinia Pharmaceuticals Inc. |
2020-05-30 |
| NCT04144413 |
3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis® (1mg/mL Ciclosporin) |
https://ClinicalTrials.gov/show/NCT04144413 |
Recruiting |
Santen SAS |
2023-05-31 |
| NCT04143841 |
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04143841 |
Recruiting |
Epitech Mag Ltd. |
2020-10-31 |
| NCT04139122 |
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04139122 |
Completed |
Senju Pharmaceutical Co., Ltd. |
2020-03-03 |
| NCT04125134 |
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests |
https://ClinicalTrials.gov/show/NCT04125134 |
Recruiting |
Tufts Medical Center |
2020-05-31 |
| NCT04120584 |
Clinical Evaluation of Safety and Efficacy of Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction |
https://ClinicalTrials.gov/show/NCT04120584 |
Recruiting |
InMode MD Ltd. |
2020-10-31 |
| NCT04115800 |
Liposomal Sirolimus in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04115800 |
Recruiting |
Instituto de OftalmologÃa Fundación Conde de Valenciana |
2020-05-01 |
| NCT04105842 |
Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type |
https://ClinicalTrials.gov/show/NCT04105842 |
Recruiting |
University of Waterloo |
2020-02-28 |
| NCT04100031 |
Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT04100031 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2020-06-06 |
| NCT04096898 |
Senofilcon A Lenses in Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04096898 |
Recruiting |
University of Illinois at Chicago |
2020-12-31 |
| NCT04092907 |
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT04092907 |
Completed |
Harbour BioMed (Guangzhou) Co. Ltd. |
2019-07-03 |
| NCT04091581 |
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye |
https://ClinicalTrials.gov/show/NCT04091581 |
Completed |
University of Waterloo |
2020-02-06 |
| NCT04084483 |
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04084483 |
Completed |
Kowa Research Institute, Inc. |
2020-01-03 |
| NCT04081610 |
Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT04081610 |
Recruiting |
Laboratorios Sophia S.A de C.V. |
2019-12-20 |
| NCT04063644 |
Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT04063644 |
Recruiting |
OPKO Health, Inc. |
2020-05-31 |
| NCT04036292 |
Clinical Trial to Evaluate the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-2 Study) |
https://ClinicalTrials.gov/show/NCT04036292 |
Active, not recruiting |
Oyster Point Pharma, Inc. |
2020-05-08 |
| NCT04030962 |
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04030962 |
Recruiting |
Allergan |
2020-09-30 |
| NCT04022382 |
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion |
https://ClinicalTrials.gov/show/NCT04022382 |
Completed |
The Eye Care Institute |
2019-08-26 |
| NCT04015219 |
Management of Signs and Symptoms Associated With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT04015219 |
Recruiting |
Tissue Tech Inc. |
2020-07-01 |
| NCT03992482 |
IVIG-eye Drops Treatment for Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03992482 |
Completed |
University of Illinois at Chicago |
2019-08-02 |
| NCT03992287 |
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Dry Eye |
https://ClinicalTrials.gov/show/NCT03992287 |
Recruiting |
Chonbuk National University Hospital |
2020-03-30 |
| NCT03982368 |
A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT03982368 |
Recruiting |
Dompé Farmaceutici S.p.A |
2020-03-31 |
| NCT03956225 |
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study |
https://ClinicalTrials.gov/show/NCT03956225 |
Active, not recruiting |
Alcon Research |
2020-10-31 |
| NCT03925727 |
Tavilermide Ophthalmic Solution for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT03925727 |
Recruiting |
Mimetogen Pharmaceuticals USA, Inc. |
2020-02-29 |
| NCT03923244 |
Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface |
https://ClinicalTrials.gov/show/NCT03923244 |
Completed |
University Hospital, Clermont-Ferrand |
2020-03-06 |
| NCT03916042 |
A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03916042 |
Active, not recruiting |
Aldeyra Therapeutics, Inc. |
2020-04-30 |
| NCT03907865 |
Clinical Efficacy of Topical Hydrocortisone 0.335% (Softacort®) in Patients With Chronic Dry Eye Disease and Associated Ocular Surface Inflammation |
https://ClinicalTrials.gov/show/NCT03907865 |
Completed |
Medical University of Vienna |
2018-11-28 |
| NCT03889886 |
Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03889886 |
Active, not recruiting |
Silk Technologies, Ltd. |
2020-01-31 |
| NCT03879863 |
The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03879863 |
Active, not recruiting |
Aldeyra Therapeutics, Inc. |
2021-04-30 |
| NCT03874429 |
Efficacy of T2259 in DED |
https://ClinicalTrials.gov/show/NCT03874429 |
Recruiting |
Laboratoires Thea |
2020-03-01 |
| NCT03873246 |
Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study) |
https://ClinicalTrials.gov/show/NCT03873246 |
Completed |
Oyster Point Pharma, Inc. |
2020-01-07 |
| NCT03865888 |
Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome |
https://ClinicalTrials.gov/show/NCT03865888 |
Completed |
Cairo University |
2019-02-01 |
| NCT03857919 |
TearCare System to Treat Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03857919 |
Recruiting |
Sight Sciences, Inc. |
2019-10-31 |
| NCT03846453 |
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes |
https://ClinicalTrials.gov/show/NCT03846453 |
Recruiting |
HanAll BioPharma Co., Ltd. |
2019-11-30 |
| NCT03833882 |
Evaluation of MAF-1217 in Patients With DED |
https://ClinicalTrials.gov/show/NCT03833882 |
Completed |
VISUfarma SpA |
2019-06-19 |
| NCT03833388 |
Study of TOP1630 for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03833388 |
Completed |
Topivert Pharma Ltd |
2019-05-14 |
| NCT03830359 |
T2769 in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03830359 |
Completed |
Laboratoires Thea |
2019-02-18 |
| NCT03827564 |
Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03827564 |
Recruiting |
Allergan |
2020-06-30 |
| NCT03803748 |
A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® |
https://ClinicalTrials.gov/show/NCT03803748 |
Recruiting |
SIFI SpA |
2020-06-30 |
| NCT03803722 |
To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance |
https://ClinicalTrials.gov/show/NCT03803722 |
Recruiting |
SIFI SpA |
2020-06-30 |
| NCT03788486 |
Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device |
https://ClinicalTrials.gov/show/NCT03788486 |
Recruiting |
Toyos Clinic |
2020-06-01 |
| NCT03764735 |
Study of SkQ1 as Treatment for Dry-eye Syndrome |
https://ClinicalTrials.gov/show/NCT03764735 |
Completed |
Mitotech, SA |
2019-02-09 |
| NCT03723811 |
Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome. |
https://ClinicalTrials.gov/show/NCT03723811 |
Active, not recruiting |
Samjin Pharmaceutical Co., Ltd. |
2018-06-25 |
| NCT03723798 |
Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome. |
https://ClinicalTrials.gov/show/NCT03723798 |
Active, not recruiting |
Samjin Pharmaceutical Co., Ltd. |
2018-10-08 |
| NCT03719885 |
TrueTear in Sjogren’s Disease Patients |
https://ClinicalTrials.gov/show/NCT03719885 |
Recruiting |
University of Pennsylvania |
2019-07-25 |
| NCT03709641 |
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion |
https://ClinicalTrials.gov/show/NCT03709641 |
Completed |
The Eye Care Institute |
2018-11-28 |
| NCT03706443 |
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops |
https://ClinicalTrials.gov/show/NCT03706443 |
Completed |
Ohio State University |
2019-02-28 |
| NCT03693183 |
Efficacy Study of Ketorolac and HPMC to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT03693183 |
Completed |
ORA, Inc. |
2009-06-15 |
| NCT03691636 |
Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease. |
https://ClinicalTrials.gov/show/NCT03691636 |
Recruiting |
D.E.L., LLC |
2019-04-02 |
| NCT03688802 |
Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (The IMPERIAL Study) |
https://ClinicalTrials.gov/show/NCT03688802 |
Completed |
Oyster Point Pharma, Inc. |
2019-09-30 |
| NCT03682809 |
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort |
https://ClinicalTrials.gov/show/NCT03682809 |
Completed |
University of Alabama at Birmingham |
2019-03-23 |
| NCT03676335 |
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye |
https://ClinicalTrials.gov/show/NCT03676335 |
Completed |
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
2019-06-30 |
| NCT03666884 |
The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03666884 |
Completed |
Usak State Hospital |
2016-03-15 |
| NCT03660475 |
Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects |
https://ClinicalTrials.gov/show/NCT03660475 |
Completed |
Total Eye Care, PA |
2018-11-01 |
| NCT03658811 |
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03658811 |
Completed |
Toyos Clinic |
2018-10-30 |
| NCT03652051 |
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03652051 |
Recruiting |
Azura Ophthalmics |
2020-12-31 |
| NCT03640351 |
Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT03640351 |
Recruiting |
Yonsei University |
2019-08-14 |
| NCT03636061 |
Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-1 Study) |
https://ClinicalTrials.gov/show/NCT03636061 |
Completed |
Oyster Point Pharma, Inc. |
2018-09-26 |
| NCT03633461 |
Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study) |
https://ClinicalTrials.gov/show/NCT03633461 |
Completed |
Oyster Point Pharma, Inc. |
2018-09-20 |
| NCT03617315 |
Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye |
https://ClinicalTrials.gov/show/NCT03617315 |
Completed |
University of Seville |
2018-02-01 |
| NCT03616899 |
Safety and Efficacy of KPI-121 in Subjects With DED |
https://ClinicalTrials.gov/show/NCT03616899 |
Completed |
Kala Pharmaceuticals, Inc. |
2020-02-05 |
| NCT03608761 |
Comparison Between Rebamipide 2% Versus Autologous Serum |
https://ClinicalTrials.gov/show/NCT03608761 |
Completed |
Hospital Nacional Profesor Alejandro Posadas |
2017-10-09 |
| NCT03598699 |
A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (DED) |
https://ClinicalTrials.gov/show/NCT03598699 |
Active, not recruiting |
AxeroVision, Inc. |
2019-03-31 |
| NCT03597139 |
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03597139 |
Completed |
Aurinia Pharmaceuticals Inc. |
2018-11-09 |
| NCT03588624 |
Study of the TearCare System in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03588624 |
Recruiting |
Sight Sciences, Inc. |
2018-09-30 |
| NCT03569202 |
Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT03569202 |
Completed |
Kuopio University Hospital |
2018-11-08 |
| NCT03527212 |
A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03527212 |
Completed |
Senju Pharmaceutical Co., Ltd. |
2019-03-15 |
| NCT03519815 |
Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03519815 |
Completed |
University of Applied Sciences and Arts Northwestern Switzerland |
2018-10-30 |
| NCT03492541 |
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03492541 |
Completed |
Alcon Research |
2019-04-30 |
| NCT03467490 |
Self-care Management Program for Dry Eye Disease Patients Using the heiQ |
https://ClinicalTrials.gov/show/NCT03467490 |
Active, not recruiting |
Lawson Health Research Institute |
2019-01-19 |
| NCT03436576 |
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT03436576 |
Enrolling by invitation |
Pontificia Universidad Catolica de Chile |
2018-10-19 |
| NCT03418727 |
Dry Eye Disease Study With Brimonidine |
https://ClinicalTrials.gov/show/NCT03418727 |
Completed |
Ocugen |
2018-03-29 |
| NCT03418259 |
Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome) |
https://ClinicalTrials.gov/show/NCT03418259 |
Recruiting |
Karolinska Institutet |
2021-12-31 |
| NCT03417505 |
Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye |
https://ClinicalTrials.gov/show/NCT03417505 |
Completed |
Tangible Science |
2019-01-04 |
| NCT03414645 |
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease |
https://ClinicalTrials.gov/show/NCT03414645 |
Recruiting |
Cambium Medical Technologies LLC |
2019-09-30 |
| NCT01268735 |
The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye |
https://ClinicalTrials.gov/show/NCT01268735 |
Completed |
University of Zagreb |
2009-09-30 |
| NCT01257607 |
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT01257607 |
Completed |
Mimetogen Pharmaceuticals USA, Inc. |
2011-05-31 |
| NCT01250171 |
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01250171 |
Completed |
Novartis |
2011-09-30 |
| NCT01240382 |
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01240382 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2008-02-29 |
| NCT01239069 |
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01239069 |
Completed |
Santen Inc. |
2011-10-31 |
| NCT01235234 |
Trial of CF101 to Treat Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01235234 |
Completed |
Can-Fite BioPharma |
2013-11-30 |
| NCT01223040 |
An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye |
https://ClinicalTrials.gov/show/NCT01223040 |
Completed |
Alcon Research |
2010-09-30 |
| NCT01212471 |
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01212471 |
Completed |
Bausch & Lomb Incorporated |
2011-08-31 |
| NCT01211951 |
A Study of KCT-0809 in Patients With Dry Eye Syndromes |
https://ClinicalTrials.gov/show/NCT01211951 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
NA |
| NCT01203540 |
Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients |
https://ClinicalTrials.gov/show/NCT01203540 |
Completed |
Laboratoires Thea |
NA |
| NCT01189032 |
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01189032 |
Completed |
Santen Pharmaceutical Co., Ltd. |
2006-07-31 |
| NCT01178242 |
Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome. |
https://ClinicalTrials.gov/show/NCT01178242 |
Completed |
Federal University of São Paulo |
2010-04-30 |
| NCT01165164 |
An Evaluation of the Nighttime Retention of Effect of an Investigational Lubricant Eye Drop (FID 115958D) |
https://ClinicalTrials.gov/show/NCT01165164 |
Completed |
Alcon Research |
2010-07-31 |
| NCT01163643 |
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01163643 |
Completed |
Bausch & Lomb Incorporated |
2011-06-30 |
| NCT01160133 |
To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops |
https://ClinicalTrials.gov/show/NCT01160133 |
Completed |
Alcon Research |
2011-06-30 |
| NCT01139372 |
An Evaluation of the Daytime Use of an Investigational Lubricant Eye Drop |
https://ClinicalTrials.gov/show/NCT01139372 |
Completed |
Alcon Research |
2010-06-30 |
| NCT01135511 |
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01135511 |
Completed |
Pfizer |
2011-04-30 |
| NCT01129856 |
Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT01129856 |
Completed |
Eyegate Pharmaceuticals, Inc. |
2011-01-31 |
| NCT01128049 |
Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation |
https://ClinicalTrials.gov/show/NCT01128049 |
Completed |
University of Rochester |
2011-12-31 |
| NCT01118754 |
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT01118754 |
Completed |
Santen Inc. |
2010-12-31 |
| NCT01107964 |
Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT01107964 |
Completed |
Milton S. Hershey Medical Center |
2014-08-31 |
| NCT01105910 |
Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye |
https://ClinicalTrials.gov/show/NCT01105910 |
Completed |
Alcon Research |
2010-12-31 |
| NCT01105624 |
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE) |
https://ClinicalTrials.gov/show/NCT01105624 |
Completed |
Merck Sharp & Dohme Corp. |
2010-11-30 |
| NCT01105221 |
Acupuncture for Dry Eye |
https://ClinicalTrials.gov/show/NCT01105221 |
Completed |
Korea Institute of Oriental Medicine |
2010-11-30 |
| NCT01102257 |
Dry Eye Assessment and Management: Feasibility Study |
https://ClinicalTrials.gov/show/NCT01102257 |
Completed |
Asbell, Penny, M.D. |
2010-07-31 |
| NCT01101984 |
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01101984 |
Completed |
Santen Pharmaceutical Co., Ltd. |
NA |
| NCT01077011 |
Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Lubricant Eye Gel |
https://ClinicalTrials.gov/show/NCT01077011 |
Completed |
Alcon Research |
2010-01-31 |
| NCT01076998 |
Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye Ointment |
https://ClinicalTrials.gov/show/NCT01076998 |
Completed |
Alcon Research |
2010-01-31 |
| NCT01061268 |
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens |
https://ClinicalTrials.gov/show/NCT01061268 |
Completed |
Innovative Medical |
2012-02-29 |
| NCT01057147 |
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea |
https://ClinicalTrials.gov/show/NCT01057147 |
Completed |
Kubota Vision Inc. |
2011-01-31 |
| NCT01051804 |
Evaluation of the Repeated Usage of Systane Ultra Eyedrop |
https://ClinicalTrials.gov/show/NCT01051804 |
Completed |
Alcon Research |
2010-07-31 |
| NCT01030237 |
An Evaluation of the Safety and Efficacy of FID 114657 |
https://ClinicalTrials.gov/show/NCT01030237 |
Completed |
Alcon Research |
2010-01-31 |
| NCT01027013 |
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01027013 |
Completed |
Kubota Vision Inc. |
2010-10-31 |
| NCT01015209 |
Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers |
https://ClinicalTrials.gov/show/NCT01015209 |
Completed |
Medical University of Vienna |
2010-10-31 |
| NCT01014078 |
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT01014078 |
Completed |
Merck Sharp & Dohme Corp. |
2010-03-31 |
| NCT01013077 |
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability |
https://ClinicalTrials.gov/show/NCT01013077 |
Completed |
Southern California College of Optometry |
2011-03-31 |
| NCT01010282 |
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects |
https://ClinicalTrials.gov/show/NCT01010282 |
Completed |
Allergan |
2010-04-30 |
| NCT00995189 |
Clinical Evaluation of the Causes of Contact Lens Related Dry Eye |
https://ClinicalTrials.gov/show/NCT00995189 |
Completed |
Alcon Research |
2010-04-30 |
| NCT00987727 |
Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye |
https://ClinicalTrials.gov/show/NCT00987727 |
Completed |
Allergan |
2010-07-31 |
| NCT00983203 |
Acute Comfort and Haze Profile of FID 114657 |
https://ClinicalTrials.gov/show/NCT00983203 |
Completed |
Alcon Research |
2009-08-31 |
| NCT00969280 |
Acupuncture for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00969280 |
Completed |
Korea Institute of Oriental Medicine |
2009-12-31 |
| NCT00946777 |
Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days |
https://ClinicalTrials.gov/show/NCT00946777 |
Completed |
Alcon Research |
2009-09-30 |
| NCT00938951 |
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance. |
https://ClinicalTrials.gov/show/NCT00938951 |
Completed |
Alcon Research |
2009-07-31 |
| NCT00938704 |
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms |
https://ClinicalTrials.gov/show/NCT00938704 |
Completed |
Allergan |
2009-06-30 |
| NCT00932477 |
Safety and Tolerability of Artificial Tears in Dry Eye Subjects |
https://ClinicalTrials.gov/show/NCT00932477 |
Completed |
Allergan |
2009-09-30 |
| NCT00926185 |
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE) |
https://ClinicalTrials.gov/show/NCT00926185 |
Completed |
Shire |
2010-02-28 |
| NCT00893139 |
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye |
https://ClinicalTrials.gov/show/NCT00893139 |
Completed |
Alcon Research |
2010-01-31 |
| NCT00885079 |
Confirmatory Study of OPC-12759 Ophthalmic Suspension |
https://ClinicalTrials.gov/show/NCT00885079 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2010-03-31 |
| NCT00883649 |
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye |
https://ClinicalTrials.gov/show/NCT00883649 |
Completed |
Virginia Eye Consultants |
2011-12-31 |
| NCT00851734 |
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS) |
https://ClinicalTrials.gov/show/NCT00851734 |
Completed |
Lux Biosciences, Inc. |
2009-03-31 |
| NCT00840268 |
A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT00840268 |
Completed |
Alcon Research |
2009-07-31 |
| NCT04093037 |
Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye |
https://ClinicalTrials.gov/show/NCT04093037 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2021-07-31 |
| NCT03878628 |
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03878628 |
Recruiting |
Rigshospitalet, Denmark |
2020-04-30 |
| NCT03461575 |
Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT03461575 |
Completed |
Huons Co., Ltd. |
2018-07-12 |
| NCT03451396 |
Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms |
https://ClinicalTrials.gov/show/NCT03451396 |
Completed |
Lifelong Vision Foundation |
2018-02-01 |
| NCT00832130 |
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye |
https://ClinicalTrials.gov/show/NCT00832130 |
Completed |
TearScience, Inc. |
2009-06-30 |
| NCT00831662 |
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637) |
https://ClinicalTrials.gov/show/NCT00831662 |
Completed |
Merck Sharp & Dohme Corp. |
2009-12-31 |
| NCT03888183 |
Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03888183 |
Recruiting |
Chang Gung Memorial Hospital |
2020-01-22 |
| NCT03768115 |
Autologous Plasma Treatment for Severe Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT03768115 |
Recruiting |
Singapore National Eye Centre |
2023-12-31 |
| NCT03322917 |
Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma |
https://ClinicalTrials.gov/show/NCT03322917 |
Completed |
Vissum, Instituto Oftalmológico de Alicante |
2013-01-17 |
| NCT02986750 |
Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02986750 |
Completed |
Medical University of Vienna |
2017-03-23 |
| NCT02461719 |
Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes |
https://ClinicalTrials.gov/show/NCT02461719 |
Completed |
Taejoon Pharmaceutical Co., Ltd. |
2014-09-30 |
| NCT01890941 |
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes |
https://ClinicalTrials.gov/show/NCT01890941 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
2014-03-31 |
| NCT00814944 |
A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model |
https://ClinicalTrials.gov/show/NCT00814944 |
Completed |
Santen Inc. |
2009-10-31 |
| NCT00814515 |
Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00814515 |
Completed |
Santen SAS |
2009-09-30 |
| NCT00809198 |
Kynex Versus Refresh Plus Study in Subject With Dry Eye |
https://ClinicalTrials.gov/show/NCT00809198 |
Completed |
Alcon Research |
2009-05-31 |
| NCT01933165 |
Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer Thickness |
https://ClinicalTrials.gov/show/NCT01933165 |
Completed |
Singapore National Eye Centre |
2014-02-28 |
| NCT01718028 |
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects |
https://ClinicalTrials.gov/show/NCT01718028 |
Completed |
Alcon Research |
2012-10-31 |
| NCT01387347 |
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT01387347 |
Completed |
ReGenTree, LLC |
2011-10-31 |
| NCT00804791 |
Residence Time Evaluation of Marketed OTC Ophthalmic Products |
https://ClinicalTrials.gov/show/NCT00804791 |
Completed |
Alcon Research |
2009-02-28 |
| NCT00802399 |
Partial Lacrimal Punctual Occlusion |
https://ClinicalTrials.gov/show/NCT00802399 |
Completed |
University of Sao Paulo General Hospital |
2008-11-30 |
| NCT04063735 |
Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia |
https://ClinicalTrials.gov/show/NCT04063735 |
Completed |
Chung Shan Medical University |
2017-02-07 |
| NCT03089580 |
Intense Pulsed Light Study for Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03089580 |
Completed |
University of Michigan |
2018-11-01 |
| NCT03048526 |
Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT03048526 |
Completed |
Novaliq GmbH |
2017-04-18 |
| NCT02985827 |
Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra) |
https://ClinicalTrials.gov/show/NCT02985827 |
Completed |
ORA, Inc. |
2016-01-31 |
| NCT02492412 |
Efficacy and Safety of HE10 for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT02492412 |
Completed |
Huons Co., Ltd. |
2014-07-31 |
| NCT02554084 |
Optical Coherence Tomography of Tear Film Dynamics In-Vivo |
https://ClinicalTrials.gov/show/NCT02554084 |
Completed |
University of Rochester |
2017-09-30 |
| NCT02066896 |
Laser Therapy to Treat the Dry Mouth of Sjogren’s Syndrome |
https://ClinicalTrials.gov/show/NCT02066896 |
Completed |
Federal University of São Paulo |
2016-08-31 |
| NCT03920215 |
Clinical Trial to Evaluate the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study) |
https://ClinicalTrials.gov/show/NCT03920215 |
Completed |
Oyster Point Pharma, Inc. |
2019-10-12 |
| NCT03848221 |
Direct Application of Systane Complete to Contact Lenses |
https://ClinicalTrials.gov/show/NCT03848221 |
Completed |
University of Alabama at Birmingham |
2019-10-20 |
| NCT01086774 |
Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects |
https://ClinicalTrials.gov/show/NCT01086774 |
Completed |
Alcon Research |
2010-11-30 |
| NCT00788229 |
Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00788229 |
Completed |
Dhp Korea Co., Ltd. |
2009-08-31 |
| NCT00784719 |
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye. |
https://ClinicalTrials.gov/show/NCT00784719 |
Completed |
Pfizer |
2009-10-31 |
| NCT00781092 |
A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes |
https://ClinicalTrials.gov/show/NCT00781092 |
Completed |
Durrie Vision |
2009-03-31 |
| NCT00779987 |
Autologous Serum Efficacy Study in Patients With Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT00779987 |
Completed |
University of Chile |
2008-12-31 |
| NCT00765804 |
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT00765804 |
Completed |
Eyegate Pharmaceuticals, Inc. |
2009-02-28 |
| NCT00761202 |
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT00761202 |
Completed |
Allergan |
2008-06-30 |
| NCT00760045 |
Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time |
https://ClinicalTrials.gov/show/NCT00760045 |
Completed |
Alcon Research |
2008-10-31 |
| NCT00758784 |
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00758784 |
Completed |
Bausch & Lomb Incorporated |
2009-06-30 |
| NCT00756093 |
Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops |
https://ClinicalTrials.gov/show/NCT00756093 |
Completed |
Alcon Research |
2008-09-30 |
| NCT00748865 |
Acute Comfort and Blur of Systane Ultra and Systane |
https://ClinicalTrials.gov/show/NCT00748865 |
Completed |
Alcon Research |
2008-08-31 |
| NCT00743249 |
Punctal Plug Study to Determine the Safety and Retention Times of Various Lengths of Canalicular Stents in Volunteers |
https://ClinicalTrials.gov/show/NCT00743249 |
Completed |
Alcon Research |
2009-02-28 |
| NCT00739713 |
Effects of Sea Buckthorn Oil on Dry Eye |
https://ClinicalTrials.gov/show/NCT00739713 |
Completed |
University of Turku |
2009-03-31 |
| NCT00739349 |
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00739349 |
Completed |
Santen SAS |
2009-01-31 |
| NCT00735865 |
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion |
https://ClinicalTrials.gov/show/NCT00735865 |
Completed |
Lahey Clinic |
2009-04-30 |
| NCT00724412 |
Evaluate Artificial Tear Efficacy in Moderate to Severe Dry Eye |
https://ClinicalTrials.gov/show/NCT00724412 |
Completed |
Alcon Research |
2009-02-28 |
| NCT00721656 |
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes |
https://ClinicalTrials.gov/show/NCT00721656 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
NA |
| NCT00681265 |
Tear Film Break-up Time After Instillation of Artificial Tears |
https://ClinicalTrials.gov/show/NCT00681265 |
Completed |
Eyeon Therapeutics, Inc. |
2008-08-31 |
| NCT00680108 |
A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution |
https://ClinicalTrials.gov/show/NCT00680108 |
Completed |
Merck Sharp & Dohme Corp. |
2000-05-31 |
| NCT00679718 |
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00679718 |
Completed |
Merck Sharp & Dohme Corp. |
2000-07-31 |
| NCT00673959 |
Acute Comfort of Lubricant Eye Drop FID 111421 |
https://ClinicalTrials.gov/show/NCT00673959 |
Completed |
Alcon Research |
2008-02-29 |
| NCT00673855 |
Acute Comfort of Lubricant Eye Drops FID 112903 |
https://ClinicalTrials.gov/show/NCT00673855 |
Completed |
Alcon Research |
2008-05-31 |
| NCT00667004 |
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00667004 |
Completed |
Bausch & Lomb Incorporated |
2008-12-31 |
| NCT00622037 |
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality |
https://ClinicalTrials.gov/show/NCT00622037 |
Completed |
Bp Consulting, Inc |
2008-05-31 |
| NCT00620893 |
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK). |
https://ClinicalTrials.gov/show/NCT00620893 |
Completed |
Bp Consulting, Inc |
2009-05-31 |
| NCT00610480 |
Effects of Tear Film Stability After Instillation Of OTC Artificial Drops |
https://ClinicalTrials.gov/show/NCT00610480 |
Completed |
University of Texas Southwestern Medical Center |
2009-03-31 |
| NCT00607776 |
Artificial Tears Study in Mild to Moderate Dry Eye Patients |
https://ClinicalTrials.gov/show/NCT00607776 |
Completed |
Abbott Medical Optics |
NA |
| NCT00600288 |
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634) |
https://ClinicalTrials.gov/show/NCT00600288 |
Completed |
Merck Sharp & Dohme Corp. |
2008-05-31 |
| NCT00599716 |
Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00599716 |
Completed |
Lantibio |
2008-04-30 |
| NCT00568386 |
Acute Comfort and Blur of Systane and Optive |
https://ClinicalTrials.gov/show/NCT00568386 |
Completed |
Alcon Research |
NA |
| NCT00567177 |
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00567177 |
Completed |
Innovative Medical |
NA |
| NCT00565669 |
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT00565669 |
Completed |
Medical University of South Carolina |
2008-10-31 |
| NCT00560638 |
Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00560638 |
Completed |
Bausch & Lomb Incorporated |
2006-02-28 |
| NCT00554879 |
Acupuncture Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00554879 |
Completed |
Walter Reed Army Medical Center |
2011-02-28 |
| NCT00549289 |
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006) |
https://ClinicalTrials.gov/show/NCT00549289 |
Completed |
Sirion Therapeutics, Inc. |
NA |
| NCT00548301 |
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007) |
https://ClinicalTrials.gov/show/NCT00548301 |
Completed |
Sirion Therapeutics, Inc. |
NA |
| NCT00535054 |
Study to Assess the Safety and Patients’ Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT00535054 |
Completed |
Trima, Israel Pharmaceutical Products |
2010-02-28 |
| NCT00520260 |
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase |
https://ClinicalTrials.gov/show/NCT00520260 |
Completed |
Florida Eye Microsurgical Institute |
2008-08-31 |
| NCT00514852 |
Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00514852 |
Completed |
Allergan |
2008-01-31 |
| NCT00502073 |
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005) |
https://ClinicalTrials.gov/show/NCT00502073 |
Completed |
Sirion Therapeutics, Inc. |
NA |
| NCT00475319 |
Late Phase 2 Study of OPC-12759 Ophthalmic Suspension |
https://ClinicalTrials.gov/show/NCT00475319 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2008-03-31 |
| NCT00471419 |
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00471419 |
Completed |
Alcon Research |
2007-08-31 |
| NCT00469573 |
Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes |
https://ClinicalTrials.gov/show/NCT00469573 |
Completed |
Innovative Medical |
2008-03-31 |
| NCT00442273 |
Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00442273 |
Completed |
Chonnam National University Hospital |
NA |
| NCT00439400 |
A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period |
https://ClinicalTrials.gov/show/NCT00439400 |
Completed |
Alacrity Biosciences, Inc. |
NA |
| NCT00426543 |
Effect of B-cell Depletion in Patients With Primary Sjögren’s Syndrome |
https://ClinicalTrials.gov/show/NCT00426543 |
Completed |
University of Copenhagen |
2010-06-30 |
| NCT00799682 |
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® |
https://ClinicalTrials.gov/show/NCT00799682 |
Completed |
Ophthalmic Consultants of Long Island |
2011-01-31 |
| NCT00799552 |
Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye |
https://ClinicalTrials.gov/show/NCT00799552 |
Completed |
Resolvyx Pharmaceuticals, Inc |
2009-05-31 |
| NCT00407043 |
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis |
https://ClinicalTrials.gov/show/NCT00407043 |
Completed |
Ophthalmic Consultants of Long Island |
2007-09-30 |
| NCT00405457 |
Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT00405457 |
Completed |
Innovative Medical |
2008-01-31 |
| NCT00404131 |
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00404131 |
Completed |
Merck Sharp & Dohme Corp. |
2001-12-31 |
| NCT00403975 |
Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00403975 |
Completed |
Merck Sharp & Dohme Corp. |
2004-11-30 |
| NCT00403715 |
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease |
https://ClinicalTrials.gov/show/NCT00403715 |
Completed |
Merck Sharp & Dohme Corp. |
2002-09-30 |
| NCT00399230 |
A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00399230 |
Completed |
Innovative Medical |
NA |
| NCT00399061 |
Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms |
https://ClinicalTrials.gov/show/NCT00399061 |
Completed |
Innovative Medical |
2008-09-30 |
| NCT00395759 |
The Visual Effect of an Investigational Artificial Tear in the Tear Layer. |
https://ClinicalTrials.gov/show/NCT00395759 |
Completed |
Southern California College of Optometry |
NA |
| NCT00388791 |
Comparison of Systane Free vs. Saline in the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00388791 |
Completed |
Southern California College of Optometry |
NA |
| NCT00386646 |
Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITEâ„¢) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye |
https://ClinicalTrials.gov/show/NCT00386646 |
Completed |
Chulalongkorn University |
NA |
| NCT00370747 |
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00370747 |
Completed |
Bausch & Lomb Incorporated |
2007-06-30 |
| NCT00357201 |
Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00357201 |
Completed |
Laboratoires Thea |
NA |
| NCT00349466 |
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT00349466 |
Completed |
Can-Fite BioPharma |
2009-05-31 |
| NCT00349440 |
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy |
https://ClinicalTrials.gov/show/NCT00349440 |
Completed |
Innovative Medical |
2008-09-30 |
| NCT00345241 |
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points |
https://ClinicalTrials.gov/show/NCT00345241 |
Completed |
University of Texas Southwestern Medical Center |
2006-12-31 |
| NCT00344721 |
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00344721 |
Completed |
University of Texas Southwestern Medical Center |
2008-10-31 |
| NCT00335114 |
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers |
https://ClinicalTrials.gov/show/NCT00335114 |
Completed |
University of Alabama at Birmingham |
NA |
| NCT00234078 |
Dose-response Study of OPC-12759 Ophthalmic Suspension |
https://ClinicalTrials.gov/show/NCT00234078 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2006-04-30 |
| NCT00201981 |
Study of Rebamipide Eye Drops to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT00201981 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
NA |
| NCT00201955 |
Study of Rebamipide Eye Drops to Treat Dry Eye |
https://ClinicalTrials.gov/show/NCT00201955 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
NA |
| NCT00198536 |
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00198536 |
Completed |
Bausch & Lomb Incorporated |
2005-12-31 |
| NCT00128245 |
Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca |
https://ClinicalTrials.gov/show/NCT00128245 |
Completed |
Novartis |
2006-12-31 |
| NCT00001731 |
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops |
https://ClinicalTrials.gov/show/NCT00001731 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037661 |
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye |
https://ClinicalTrials.gov/show/NCT00037661 |
Completed |
Merck Sharp & Dohme Corp. |
2003-03-31 |
| NCT00818324 |
Long Term Administration Study of OPC-12759 Ophthalmic Suspension |
https://ClinicalTrials.gov/show/NCT00818324 |
Completed |
Otsuka Pharmaceutical Co., Ltd. |
2010-09-30 |
| NCT00025818 |
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome |
https://ClinicalTrials.gov/show/NCT00025818 |
Completed |
Allergan |
2003-03-31 |